Based on our analysis, the late RISS, ISS staging, high-risk genetic status, anemia, high serum globulin level, and low albumin levels were strongly associated with shorter PFS, which corroborates with published clinical trials and findings within clinical practice [34, 41]. This evidence concerns the gene ALB and anemia.